B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 4 610 KRW 1.32% Market Closed
Market Cap: 262.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Net Margin
BioPlus Co Ltd

39.3%
Current
36%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
39.3%
=
Net Income
25.6B
/
Revenue
65B

Net Margin Across Competitors

Country KR
Market Cap 263.6B KRW
Net Margin
39%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.4B CHF
Net Margin
11%
Country DK
Market Cap 204.6B DKK
Net Margin
19%
Country US
Market Cap 16.6B USD
Net Margin
11%
Country CN
Market Cap 52.9B CNY
Net Margin
42%
Country CA
Market Cap 6.9B USD
Net Margin
-8%
Country UK
Market Cap 5B GBP
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Net Margin
14%
Country US
Market Cap 5.9B USD
Net Margin
9%
Country US
Market Cap 5.6B USD
Net Margin
29%

Profitability Report

View the profitability report to see the full profitability analysis for BioPlus Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
39.3%
=
Net Income
25.6B
/
Revenue
65B
What is the Net Margin of BioPlus Co Ltd?

Based on BioPlus Co Ltd's most recent financial statements, the company has Net Margin of 39.3%.